Back

Cara Therapeutics Quote, Financials, Valuation and Earnings

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.

Sell

CARA
Cara Therapeutics

Last Price:

0.77

Seasonality Move:

2.16%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold

The result is a select group of high-quality blue-chip stocks.

Cara Therapeutics Price Quote

$0.77

-0.01 (4.27%)

(Updated: May 3, 2024 at 4:00 AM ET)

Cara Therapeutics Key Stats

Sell

Cara Therapeutics (CARA) is a Sell

Day range:

$0.74 - $0.79

52-week range:

$0.50 - $4.67

Dividend yield:

P/E ratio:

0.00

P/S ratio:

2.02

P/B ratio:

0.75%

Volume:

169.4K

Avg. volume:

354.1K

1-year change:

-80.9%

Market cap:

$42.7M

Revenue:

$21M

EPS:

$-2.19

How Much Does Cara Therapeutics Make?

How Much Are Cara Therapeutics's Sales Annually?
CARA Revenues are $21M
How Much Profit Does Cara Therapeutics's Make A Year?
CARA net income is -$118.5M

Is Cara Therapeutics Growing As A Company?

What Is Cara Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.08%
What Is Cara Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Cara Therapeutics Stock Price Performance

Did Cara Therapeutics Stock Go Up Last Month?
Cara Therapeutics share price went down by -15.05% last month
Did CARA's Share Price Rise Over The Last Year?
CARA share price fell by -80.9% over the past 1 year

What Is Cara Therapeutics 52-Week High & Low?

What Is Cara Therapeutics’s 52-Week High Share Price?
Cara Therapeutics has traded as high as $4.67 over the past 52 weeks
What Is Cara Therapeutics’s 52-Week Low Share Price?
Cara Therapeutics has traded as low as $0.50 over the past 52 weeks

Cara Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cara Therapeutics?

How Much Debt Does Cara Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Cara Therapeutics Have?
Cash and short term investments quarterly total is $100.8M
What Is Cara Therapeutics’s Book Value Per Share?
Book value per share is 1.05

Is Cara Therapeutics Cash Flow Positive?

What Is CARA Cash Flow From Operations?
Cash flow from operations (TTM) is -$92.1M
What Is Cara Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $38.2M
What Is Cara Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $43.5M

Cara Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
CARA return on invested capital is -108.32%
What Is Cara Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -83.33%
What Is CARA Return On Equity?
ROE is a measure of profitability and is -108.32%

Cara Therapeutics Earnings Date & Stock Price

What Is Cara Therapeutics's Stock Price Today?
A single share of CARA can be purchased today for 0.78
What Is Cara Therapeutics’s Stock Symbol?
Cara Therapeutics trades on the nasdaq under the ticker symbol: CARA
When Is Cara Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Cara Therapeutics is scheduled on May 15, 2024
When Is CARA's next ex-dividend date?
Cara Therapeutics's next ex-dividend date is May 7, 2020
How To Buy Cara Therapeutics Stock?
You can buy Cara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cara Therapeutics Competitors

Who Are Cara Therapeutics's Competitors?
Below is a list of companies who compete with Cara Therapeutics or are related in some way:
- Avid Bioservices Inc (CDMO)
- Cerus Corp (CERS)
- Nektar Therapeutics (NKTR)
- Rigel Pharmaceuticals Inc (RIGL)
- Stereotaxis Inc (STXS)

Cara Therapeutics Dividend Yield